Sign Up to like & get
recommendations!
2
Published in 2022 at "Cell Death Discovery"
DOI: 10.1038/s41420-022-00845-5
Abstract: β-site APP-cleaving enzyme 2 (BACE2) is a homolog of BACE1, which is considered as the most promising therapeutic target for Alzheimer’s disease (AD). However, the expression and functional role of BACE2 in central nervous system…
read more here.
Keywords:
hscr;
bace2;
derived brain;
brain organoids ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Stroke"
DOI: 10.1161/str.51.suppl_1.tp486
Abstract: Under physiological conditions, β-site amyloid precursor protein (APP)-cleaving enzyme 2 (BACE2) cleaves APP within Aβ sequence thereby functioning like a α-secretase. However, BACE2 could also function as a conditional β-secretase during aging, contributing to Alzheimer’s…
read more here.
Keywords:
protein;
human bmecs;
precursor protein;
bace2 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Medicinal Chemistry"
DOI: 10.2210/pdb6jse/pdb
Abstract: BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer’s disease. BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments. This role of BACE2 implies that…
read more here.
Keywords:
bace2;
bace1;
structure based;
bace1 inhibitors ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2021.641152
Abstract: Hirschsprung disease (HSCR) has a higher incidence in children with Down syndrome (DS), which makes trisomy 21 a predisposing factor to HSCR. DSCAM and BACE2 are close together on the HSCR-associated critical region of chromosome…
read more here.
Keywords:
hirschsprung disease;
bace2;
han chinese;
hscr ... See more keywords